Apr 30, 2020
US Allergic Rhinitis Market and Competitive Landscape 2020
Apr 29, 2020
Pipeline Insights for Seasonal Allergic Rhinitis, with Coverage of Allergy Therapeutics, Glenmark Pharmaceutical and VentiRx Pharmaceuticals
Mar 24, 2020
Allergy Treatment Market- Growth, Trends, and Forecast (2020 - 2025)
Mar 23, 2020
The Global allergy rhinitis drugs market is expected to grow by USD 2.4 bn during 2020-2024, progressing at a CAGR of 4% during the forecast period
Oct 30, 2019
Allergy Immunotherapies Market Analysis & Potential Growth Opportunities, 2028 With Key Players: ALK-Abello, Merck, WOLW Pharma, HAL & Leti | Radiant Insights, Inc.
Aug 02, 2019
Allergy Immunotherapy Market is Projected to Expand at CAGR of 10.7%, High Occurrence of Different Allergy Types to Drive the Industry Globally - TMR
May 30, 2019
Global Allergy Immunotherapy (AIT) Market Analysis & Outlook 2019-2023 - Well Defined Pricing / Busy Peanut Drug Pipeline / Slowly Changing Regulatory Landscape
Feb 25, 2019
Glenmark Pharmaceuticals Announces Results from New Analysis of Pooled Data on Ryaltris(TM), an Investigational Product for the Treatment of Seasonal Allergic Rhinitis, at the AAAAI 2019 Annual Meeting
Feb 19, 2019
Glenmark Pharmaceuticals to Present New Analysis of Pooled Data on Ryaltris(TM), an Investigational Product for the Treatment of Seasonal Allergic Rhinitis, at the AAAAI 2019 Annual Meeting
Jan 30, 2019
Global Birch Pollen Allergy Pipeline Insights 2019 - Complete Pipeline Analysis by Developmental Stage, Associated Indications, Route of Administration and Molecule Type
Nov 13, 2018
Neurent Medical's RF-based Minimally Invasive Rhinitis Therapy Earns Acclaim from Frost & Sullivan
Nov 09, 2018
Allergy Diagnostics Market to Expand at a Spectacular CAGR of 12.80% Owing Increasing Demand for Quality Healthcare Treatments, Says TMR
Oct 30, 2018
Global Allergic Rhinitis Market and Competitive Landscape Report 2018: Key Products Marketed and Prescribed by Brand Name, Molecule, Company, Branded/Generic & Country
Oct 26, 2018
Allergy Treatment Market to Reach $40.36 Bn, Globally, by 2025 At 6.3% CAGR, Says Allied Market Research
Oct 02, 2018
The global allergic rhinitis drugs market is expected to grow at a CAGR of 3.3%
Aug 29, 2018
Global Allergic Rhinitis Drugs Market 2018-2028 - Visiongain Report
Aug 07, 2018
Glenmark Pharmaceuticals Announces FDA Acceptance of the Company's First New Drug Application for Ryaltris(TM) for Patients with Seasonal Allergic Rhinitis
Jun 22, 2018
Private Label Brands offers solution to ease respiratory tract allergy symptoms
May 21, 2018
Glenmark Pharmaceuticals Announces the Company's First New Drug Application for Ryaltris(TM) for Patients with Seasonal Allergic Rhinitis
Mar 21, 2018
AOBiome Therapeutics Reports Positive Clinical Safety Results for First-in-Class Microbiome-Targeted Therapy for Intranasal Delivery